hepatitis

Professional, molecular, and tissue diagnostics sales continued to grow during the first three quarters, while diabetes care sales remained in decline.

This Week in Nature

In Nature this week: modified CRISPR approach changes single nucleotides, new salmon genome assembly, and more.

Roche's molecular diagnostics business, which makes up 17 percent of its overall diagnostics sales, grew 11 percent, driven by virology testing and sequencing.

The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.

It's the first approved test to feature the firm's proprietary AmpiProbe nucleic acid amplification and detection platform.

This Week in PNAS

In PNAS this week: decreased DOCK4 expression in myelodysplastic syndromes plus anemia, hepatitis A evolution, and more.

A survey of small mammals from around the world uncovered new and known hepatoviruses that are helping to clarify relationships between viral clades.

The hepatitis C virus test has been approved for both the confirmation of active infection as well as for viral load monitoring.

The study demonstrated the efficacy of using the Oxford Nanopore MinIon and a bespoke computational pipeline to perform metagenomics testing of viral infections in patients. 

Researchers found a handful of individuals whose post-transfusion blood samples contained a new virus resembling hepaciviruses and pegiviruses.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.